O3.8 * Early Results: "ROCKET" a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in Colorectal Cancer
Carter, C., Reid, T., Fisher, G., Cho-Phan, C., Kunz, P., Kaiser, H., Oronsky, B., Fanger, G., Caroen, S., Parker, C., Scicinski, J.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv081.8
Date:
March, 2015
File:
PDF, 32 KB
english, 2015